tiprankstipranks
pc:alche

Alchemab Therapeutics Ltd

East Side, Office 1.02 Kings Cross London, England N1C 4AX, GB
https://www.alchemab.com/
Alchemab Therapeutics Ltd is a biotechnology company that discovers and develops therapeutic antibodies by mining human immune repertoires and identifying naturally occurring, disease-protective immune responses. The company combines systems immunology, computational analysis, and experimental validation to translate protective antibody signatures into diagnostic tools and monoclonal antibody therapeutics across multiple disease areas.

Leadership & Board

Current Number of Employees67
Current LinkedIn Followers10,919

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$32M
Total Amount Raised$32M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$32M
Latest Funding Amount$32M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Alchemab Therapeutics Ltd had 67 employees as of April 6, 2026. The number of employees increased by 3 (4.69%) week-over-week.
67Latest Employee Count
3(4.69%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Alchemab Therapeutics Ltd had 10,919 followers as of April 6, 2026. The number of followers increased by 43 (0.40%) week-over-week.
10,919Latest Followers Count
43(0.40%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 09, 2025
Series A
$32.00M

Investors

Investor Name
Funding Round

Related News and Analysis